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Background: A European web-based registry for refractive surgery was established in 2008; The European Registry
of Quality Outcomes for Cataract and Refractive Surgery (EUREQUO). The aim of the registry was to improve treatment
and standards of care for refractive surgery. Further aims were to offer a tool for benchmarking by establishing a reference
database and for surgeons to enter and analyze their own outcomes. The purpose of this study was to characterize the
registry and analyze the data collected during its first decade.
Methods: The characteristics of the web-based registry are described. Data collected from February 4th 2004 until June
30th 2014 are included in the analysis. The database is analyzed in terms of surgical technique, indications for surgery,
complications, and refractive and visual outcomes.
Results: Data have been reported from 47 centers in 14 countries until mid-2014. About 4,000 procedures were reported
annually. The most frequent procedure was laser-assisted in-situ keratomileusis (LASIK) with 11697 reported surgeries. Over
time in the database, LASIK declined (p < 0.001) while photorefractive keratectomy (PRK) and refractive lens exchange
(RLE) increased (p < 0.001 for both procedures). The indications for surgery, in terms of preoperative refraction and age,
were stable over time, for all types of procedures. Surgical complications were reported infrequently and with a
well-known relationship to the type of surgical procedure. The reported refractive outcomes were good. The
visual outcomes indicate a significant increase of visual acuity after high myopia treatment by phakic intraocular
lens in the anterior (phakic IOL AC) and the posterior (phakic IOL PC) chamber and a poorer visual outcome, after both
myopia and hyperopia treatment, by epithelial LASIK (Epi-LASIK).
Conclusions: We describe the establishment of a European registry for refractive surgery. The database increases at a rate
of approximately 4000 refractive procedures per year. The most frequent procedure is LASIK, but both PRK and RLE are an
increasing part of the reported procedures. The indications for surgery have been stable over time. Surgical complications
and visual outcome vary, depending on the type of surgery.
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In 2004, the European Society of Cataract & Refractive
Surgeons (ESCRS) took the initiative to establish a registry
for refractive surgery outcomes: the Refractive Surgery
Outcomes Information System (RSOIS). The purpose of
this web-based system was to record outcomes of refract-
ive surgery and improve quality of care for these proce-
dures. Reasons behind the initiative were the growing
health tourism within the field and increasing patient
complaints after refractive surgery reported in the press,
in some countries [1,2]. Patient complaints were thought
to be associated with inappropriate indications and sur-
gery outside the limits of the procedure, leading to sub-
optimal outcomes in refractive surgery. In addition, it is
well known that monitoring outcomes, in cataract surgery,
can make surgeons more aware of quality control, which
can lead to improved outcomes [3]. A refractive surgery
outcomes registry might reasonably be expected to have
the same influence on outcomes in refractive surgery. The
number of refractive surgeries entered into the system in-
creased slowly during the following years (personal com-
munication P. Barry). In 2007, the ESCRS applied for an
EU grant to create a European registry, aimed at improv-
ing the quality of both cataract and refractive surgery. The
philosophy behind the project was to create a database for
learning and quality improvement, not for supervision.
The EU grant application was successful, and led to the
creation of the European Registry of Quality Outcomes
for Cataract and Refractive Surgery (EUREQUO) [4,5]
with two co-financers: the European Union under the Ex-
ecutive Agency for Health and Consumers, and the
ESCRS. The ESCRS was the lead partner in the project,
and eleven national societies participated as associated
partners.
The aims of the project were to improve treatment and
standards of care for cataract and refractive surgery, and to
develop evidence-based guidelines for cataract and refract-
ive surgery across Europe. Further aims were to offer a tool
for benchmarking by establishing a reference database and
to provide a system for surgeons to record and analyze
their own outcomes. Finally, the project also served to con-
tinue the RSOIS initiative and merge data into the new
database. Details about technical, clinical, and legal issues
have been published earlier [4].
The purpose of this report is to describe the establish-
ment of a European refractive surgery database and to
describe the achievements, in terms of participating
countries, surgeons, and trends within refractive surgery,
as reflected by the growing database.Methods
A web-based system was created for input and output of
data. The system can be accessed via the EUREQUOweb portal (http://eurequo.org) for manual input of data
(Figure 1). Individual patient data are anonymous in the
registry, but for auditing purposes each participating
center guarantees traceability of a registered surgical
procedure back to the corresponding medical record in
the center. Data can also be entered into the database
from existing national registries or electronic medical
record (EMR) systems. The web-based system has built-
in security features for data protection. No field allows
the entry of free text or numbers. Instead, possible
values/options for a certain parameter are selected from
a matrix/drop-down menu, on the web page. The data-
base also contains built-in data error checks, which will
not allow impossible values for biometric parameters or
dates in incorrect chronological order (e.g. follow-up
date before surgery date, etc.) to be entered.
In refractive surgery, the goal is to achieve optimal visual
acuity, optimal refraction (usually emmetropia), and no
complications. Quality indicators reflecting these three im-
portant outcomes were decided on, and dictated the choice
of variables. Demographic and case-mix variables were also
included for accurate benchmarking. The output reports
were designed on the basis of earlier experience (RSOIS).
Each participating center/surgeon can obtain output statis-
tics from the database via the web, in the form of frequency
tables or graphs (Figure 2). The system offers one report in-
cluding preoperative and intraoperative data and one report
including follow-up data. It is also possible to export one’s
own data from the system as an Excel file. Each center/sur-
geon can only obtain access to their own data, aggregated
data for any participating country, and aggregated data for
the whole database. This means that the output data for a
particular center/surgeon can only be accessed by that cen-
ter/surgeon and also forms part of the aggregated data for
their country and for the whole database, which is access-
ible to all participating centers/surgeons. The output tables
and graphs are standardized with the option of using the
preoperative variables of gender, age, date of surgery, type
of operation, co-morbidity, and complex surgery, as filters,
allowing the participating center/surgeon to isolate and
analyze specific cohorts among their reported cases. While
this covers most of the purposes for which data output
is required, export of data as an Excel file is also pos-
sible, allowing the center/surgeon to make their own
customized output reports and perform advanced stat-
istical procedures. Follow-up data must be reported
within 6 months. There are coding guidelines for how
to report data on the web-forms [6].
The data presented here have been derived from the
EUREQUO database. Data have been entered into the
system from February 4th 2004 (in the RSOIS database
during 2004-2007 and in the EUREQUO database from
2008 onwards). Data entered until June 30th 2014 are in-
cluded in the analysis. All statistical calculations were
Figure 1 Web form for entering surgical data. This form is for preoperative data.
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version 22, IBM Ltd, Chicago, Ill. Changes over time for
surgical techniques were tested with logistic regression
analysis. A p-value of <0.05 was considered significant.
Results
The number of refractive procedures reported into the
system between February 4th, 2004 and June 30th, 2014
was 27,339. Data were entered by 47 centers/surgeons
from 14 countries. The contributing countries are Denmark,
Austria, Germany, Greece, Great Britain, Ireland, Spain,
Iceland, Belgium, The Netherlands, Slovakia, Slovenia,
Sweden and Turkey.
The number of refractive procedures reported to the
database, per annum, from 2010 onwards, was, approxi-
mately, 4000.
The most frequently reported procedure in the database
was Laser-assisted in-situ keratomileusis (LASIK) (Table 1).
The majority (95.2%) of reported refractive procedures
were primary procedures. The remaining procedures were
enhancements or additional procedures to a primary pro-
cedure. The frequency of reported surgical techniques,
changed over time (Figure 3). The proportion of LASIKprocedures decreased (p < 0.001), while photorefractive
keratectomy (PRK), refractive lens exchange (RLE) and
anterior chamber intra-ocular lenses (Phakic IOL AC) in-
creased (p < 0.001), over the study period.
The indication for surgery in terms of preoperative spher-
ical refraction and age, differed among surgical techniques
and between myopia and hyperopia. Table 2 shows the in-
dication, mean age and preoperative refraction for the most
frequently reported refractive procedures in the database.
In the refractive correction of myopia, LASIK was mainly
used for low myopic corrections, with 86% of the treated
eyes in the database having preoperative spherical equiva-
lent of less than -6.0 D. For laser-assisted subepithelial
keratectomy (LASEK) and PRK, the corresponding num-
bers were 87.6% and 89.7%, respectively. Phakic IOL AC
were used for higher myopic corrections; 31.3% of reported
phakic IOL AC cases had preoperative spherical equivalent
of -10.0 D or more, and 83.3% had -6.0 D or more. The
corresponding numbers for RLE were 13% and 47.1%,
respectively.
Trends over time, in the level of preoperative myopia,
as an indication for specific refractive procedures, are
shown in Table 3.
Figure 2 Standard graphs showing the surgical outcomes for one clinic or surgeon. The upper left graph shows attempted refraction versus achieved
refraction in Diopters. The upper right graph shows postoperative defocus of equivalent refraction in Diopters. The lower left graph shows the
postoperative spherical equivalent refraction. The lower mid graph shows the preoperative spectacle corrected visual acuity versus the postoperative
uncorrected visual acuity. Both bar rows show the accumulated frequency of visual acuity. The lower right graph shows the visual outcome in terms of
loss of one Snellen line or more, status quo or gain of one Snellen line or more.
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refractive procedures, was stable over time, in the database
(Table 4).
The mean age of patients undergoing RLE increased
(p < 0.001, linear regression) over time, but the meanTable 1 Number of refractive procedures (eyes), reported











Phakic IOL AC 1376 5.2
RLE 1155 4.3
Epi-LASIK 877 3.3
Phakic IOL PC 316 1.2
Other 1179 4.4
LASIK = Laser-assisted in-situ keratomileusis, LASEK = Laser-Assisted Subepithelial
Keratectomy, PRK = Photorefractive Keratectomy, Phakic IOL AC = Phakic intra-ocular
lens in anterior chamber, RLE = Refractive Lens Exchange, Epi-LASIK = Epithelial
LASIK, Phakic IOL PC= Phakic intra-ocular lens in posterior chamber.age of patients undergoing other refractive procedures,
remained stable.
Surgical and postoperative complications are listed in
Table 5.
Table 5 shows that Epi-LASIK had the highest reported
rate of postoperative haze, while Phakic IOL AC had the
highest reported rate of elevated intraocular pressure (IOP),
following surgery. Refractive lens exchange had the highest
reported rate of intraoperative complications, while LASIK
and PRK had the lowest reported rate of all complications.
The mean postoperative refraction (spherical equivalent),
achieved with different refractive procedures, is shown in
Table 6. The table only includes cases in which the target
postoperative refraction was 0 Diopters (D).
As shown in Table 6, the mean refractive outcome
within a follow-up time of 1 to 6 months is reported as
very good for all surgical techniques. Table 7 shows the
change in visual acuity for myopic and hyperopic treat-
ments, for various refractive procedures.
Table 7 shows a good reported visual outcome for treat-
ing high myopia with Phakic IOL AC or RLE. Poorest
visual outcome is reported for treating hyperopia with
Epi-LASIK.
Figure 3 Surface diagram showing database trend of reported type of surgical procedure. The diagram does not include the first two years because
of the limited number of cases and clinics.
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In this study, LASIK is the most frequently reported re-
fractive surgery. LASIK technique and outcome has indeed
been reported in numerous studies since the development
of this surgical technique [7,8]. However, data from real
world practice (i.e., from registries) in different countries
have been scarce. Therefore, no one has determined the
number of LASIK procedures that has been carried out in
various countries. In the EUREQUO database, the fre-
quency of a certain surgical technique may, of course,
depend on which clinics and countries data is reported
from. The second most frequently reported surgical pro-
cedure is LASEK. However, the trend in the database is aTable 2 Type of (primary) procedure, indication, mean age an
Type of procedure Indication Mean age at surgery (years) Ma
LASIK Myopia 35 −1
LASEK Myopia 34 −1
PRK Myopia 34.2 −9
Phakic IOL AC Myopia 38 −2
Epi-LASIK Myopia 35.6 −9
RLE Myopia 54.2 −2
Ma
LASIK Hyperopia 44 +1
RLE Hyperopia 56.5 +1
PRK Hyperopia 44.6 +7
LASEK Hyperopia 43 +6
Phakic IOL AC Hyperopia 33.9 +1
Epi-LASIK Hyperopia 38.5 +6
LASIK = Laser-assisted in-situ keratomileusis, LASEK = Laser-Assisted Subepithelial Keratect
anterior chamber, Epi-LASIK = Epithelial LASIK, RLE = Refractive Lens Exchange, N = numb
Refraction in Diopters.strong decrease of LASEK procedures over time. One rea-
son for this may be fear for haze as a postoperative compli-
cation [9]. The third most commonly reported procedure is
PRK. PRK takes an increasing part of the reported proce-
dures in the database. The distinction between LASEK and
PRK has become blurred: they are, essentially, the same
procedure, but in the former, the epithelium is retained,
while in the latter, it is removed. It is possible that the chan-
ging use of each is because surgeons no longer felt there
was a benefit to LASEK and that LASEK procedures were
converted preoperatively into PRK. The additional effect of
the changing trends for these three procedures probably re-
flects the fact that they all are used for the same indication:d range of preoperative refraction














omy, PRK = Photorefractive Keratectomy, Phakic IOL AC = Phakic intra-ocular lens in
er of procedures.
Table 3 Mean and maximum preoperative refraction, of myopic and hyperopic patients, who underwent various
refractive procedures
Type of refractive procedure Preoperative myopic refraction (D), reported per year
2006 2007 2008 2009 2010 2011 2012 2013 2014
LASIK Mean −3.9 −3.2 −3.5 −3.3 −3.5 −3.7 −3.5 −3.4 −3.2
Maximum −11.25 −12.0 −10.0 −11.0 −10.0 −10.25 −11.75 −10.25 −8.25
PRK Mean −3.9 −2.3 −3.7 −3.1 −2.9 −3.1 −3.5 −3.2 −3.3
Maximum −9.5 −5.5 −4.25 −8.0 −9.0 −9.5 −9.25 −8.5 −8.5
RLE Mean −6.7 * * −6.2 −5.9 −5.9 −4.7 −6.0 −7.1
Maximum −14.0 * * −6.5 −10.0 −11.75 −19.0 −20.0 −15.5
Phakic IOL AC Mean * * −7.4 −8.6 −10.3 −8.4 −8.5 −9.0 −8.3
Maximum * * −10.25 −15.25 −16.5 −20.0 −20.0 −20.0 −15.75
Epi-LASIK Mean −4.4 * * −3.5 −3.3 −2.8 −3.5 −3.25 *
Maximum −8.25 * * −6.25 −6.25 −8.0 −8.25 −9.5 *
LASEK Mean −3.2 −2.5 −4.4 −4.0 −3.4 −3.5 −3.7 −3.5 *
Maximum −10.5 −7.25 −10.5 −9.0 −10.0 −11.5 −11.25 −11.75 *
Type of refractive procedure Preoperative hyperopic refraction (D), reported per year
2006 2007 2008 2009 2010 2011 2012 2013 2014
LASIK Mean 2.7 2.1 2.5 2.4 2.5 2.4 2.2 2.3 2.5
Maximum 15.0 5.8 5.8 6.5 6.3 7.3 6.0 6.5 5.5
PRK Mean * * * * 1.4 1.4 1.5 1.2 *
Maximum * * * * 4.3 3.2 4.5 7.3 *
RLE Mean 4.4 * * * 3.1 3.4 3.0 3.2 4.5
Maximum 9.5 * * * 9.5 9.8 10.8 10.0 10.3
Phakic IOL AC Mean * * * * * 5.2 4.9 5.2 *
Maximum * * * * * 10.3 8.3 10.5 *
LASEK Mean 2.1 * * * 1.8 1.6 2.0 * *
Maximum 6.0 * * * 4.5 6.0 6.5 * *
* = Too few cases for statistical analysis, data given only if N > 30.
LASIK = Laser-assisted in-situ keratomileusis, PRK = Photorefractive Keratectomy, RLE = Refractive Lens Exchange, Phakic IOL AC = Phakic intra-ocular lens in anterior
chamber, Epi-LASIK = Epithelial LASIK, LASEK = Laser-Assisted Subepithelial Keratectomy.
The table shows trend, over time, in the database.
Table 4 Mean age of patients with myopia who underwent a refractive procedure
Type of refractive
procedure
Mean age of patients (yrs), reported per year
2006 2007 2008 2009 2010 2011 2012 2013 2014
LASIK 36.5 30.5 32.4 36.1 34.6 36.4 35.1 35.7 37.3
PRK 33.0 33.1 34.4 34.8 35.4 34.2 33.2 32.7
RLE 51.7 * * 51.4 52.6 52.6 56.2 53.8 56.6
Phakic IOL AC * * 36.8 36.2 37.8 38.7 38.2 36.6 37.2
LASEK 33.7 35.1 38.4 37.8 35.2 34.5 33.0 36.2 *
Epi-Lasik 34.4 * * 35.6 36.8 36.2 33.6 33.6 *
* = Too few cases for statistical analysis, data given only if N > 30.
LASIK = Laser-assisted in-situ keratomileusis, PRK = Photorefractive Keratectomy, RLE = Refractive Lens Exchange, Phakic IOL AC = Phakic intra-ocular lens in anterior
chamber, LASEK = Laser-Assisted Subepithelial Keratectomy, Epi-LASIK = Epithelial LASIK.
The table shows trend over time, in the database.
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Table 5 Surgical and postoperative complications (%)
LASIK LASEK PRK RLE Phakic IOL AC Epi-LASIK
Intraoperative complications (%) 0.5 0.6 0.3 1.1 0.6 0.4
Corneal complications 0.5 0.6 0.3 0.2 0.1 0.4
Flap-related 0.4 0.2 0 0 0 0
Implant-related 0 0 0 0 0 0
Other 0.1 0.4 0.3 0.2 0 0.4
Intraocular complications 0 0 0 0.9 0.5 0
PCR 0 0 0 0.3 0 0
Endothelium 0 0 0 0 0 0
Iris 0 0 0 0.2 0.3 0.
Other 0 0 0 0.4 0.3 0
Postoperative complications (%) 1.2 2.7 1.6 2.6 4.8 4.2
DLK 0.3 0 0 0 0 0
Implant-related 0 0 0 0.2 0.7 0
Corneal edema 0 0 0 0.1 0.1 0
Optical error 0.4 0.9 0 1.1 0.3 0
Haze 0 1.5 1.2 0 0 3.6
Elevated IOP 0 0.1 0 0.1 2.1 0
Infection 0 0 0 0 0.1 0
Retinal 0 0 0 0.3 0.5 0
Ectasia 0 0 0 0 0 0
Cataract 0 0 0 0.1 0.1 0
Other 0.5 0.2 0.3 0.9 1.2 0.7
All complications (%) 1.7 3.3 1.9 3.7 5.4 4.6
LASIK = Laser-assisted in-situ keratomileusis, LASEK = Laser-Assisted Subepithelial Keratectomy, PRK = Photorefractive Keratectomy, RLE = Refractive Lens Exchange,
Phakic IOL AC = Phakic intra-ocular lens in anterior chamber, Epi-LASIK = Epithelial LASIK, PCR = Posterior Capsule Rupture, DLK = Diffuse Lamellar Keratitis,
IOP = intraocular pressure.
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the increasing number of RLE cases. This procedure offers
some advantages compared with corneal refractive surgery.
It is indicated in older presbyopic patients, hyperopes, and
those with early cataract formation. The age group under-
going a refractive procedure is older, due, in part, to theTable 6 Mean refractive outcome of patients undergoing vari







Phakic IOL AC 0.015
STD = Standard Deviation, LASIK = Laser-assisted in-situ keratomileusis, LASEK = La
Epi-LASIK = Epithelial LASIK, RLE = Refractive Lens Exchange, Phakic IOL AC = Phak
Only the cases in which the target postoperative refraction was emmetropia, wereability to correct presbyopia, but they are also economically
better-off, and can afford the treatment [10].
The majority of refractive procedures in the database
were aimed at treating myopia. Low and medium myopia
was reported for LASIK, LASEK, Epi-LASIK and PRK.
These techniques were used for eyes with an averageous refractive procedures
Hyperopic treatment







ser-Assisted Subepithelial Keratectomy, PRK = Photorefractive Keratectomy,
ic intra-ocular lens in anterior chamber.
included. Follow-up was 1-6 months. Refraction in Diopters.
Table 7 Change (%) in visual outcome for myopic and hyperopic treatments, for various refractive procedures (eyes)
Refractive procedure Myopic treatment Hyperopic treatment
Change in visual acuity Loss of 1 or
more lines
Unchanged Gain of 1 or
more lines
Loss of 1 or
more lines
Unchanged Gain of 1 or
more lines
LASIK 15.1 62.7 22.1 20.3 62.2 17.5
LASEK 14.7 66.7 18.5 13.1 72.4 14.6
PRK 11.8 65.7 22.6 13.0 65.1 21.8
Epi-LASIK 28.1 57.6 14.3 37.1 60.0 14.3
RLE 8.0 52.3 39.6 18.7 55.7 25.6
Phakic IOL AC 7.2 50.6 42.2 16.9 59.7 23.4
Lundström et al. Eye and Vision  (2015) 2:8 Page 8 of 9myopia between -3.2 to -3.6 D. For higher myopia, Phakic
IOL (average -8.5 D) or RLE (average -5.8 D) were used.
Trends in the database do not show significant changes in
indications for treating myopia or hyperopia over time
(Table 3).
Complications during and after surgery are of distinct
concern as the eyes undergoing refractive surgery are
usually healthy eyes. PRK is more related to corneal
complications compared with LASIK [11]. In this study,
corneal complications in PRK are not reported in a
higher degree than LASIK except haze that is reported
in 1.2% versus 0%, respectively. LASEK and Epi-LASIK
was reported to have a higher occurrence of postopera-
tive haze in this study: 1.5% and 3.6%, respectively.
Higher frequency of haze after these two types of sur-
gery has also been reported in literature [12]. However,
the use, or no use, of mitomycin C, was not reported in
the database. It is well known that mitomycin C modifies
the formation of scar tissue, so the lack of reporting use
of mitomycin C in the database is a weakness that makes
interpretation, of the reported rate of haze, difficult. Ele-
vation of intraocular pressure may be a problem after
the use of Phakic IOL AC technique. In our study, this
was reported to occur in 2.1% of cases. This is in the
lower range of the 2 to 18% that has been reported in lit-
erature [13].
The follow-up data should be measured and entered
in the system within 1 to 6 months after surgery. This
means that refractive outcomes more than 6 months
after surgery cannot be captured in the database. The
follow-up time decided for the registry was based on
pragmatic reasons as longer follow-up means visits later
than what is normal routine for many clinics. However,
it has been reported in some studies that a long-term
follow-up may show refractive changes both after LASIK
and PRK.
The data reported in this study show a good refractive
outcome for all surgical techniques reported to the data-
base. However, the best-corrected visual outcome could be
a concern because refractive surgery is usually performed
on healthy eyes with a good preoperative visual acuity. In
this study, the surgical techniques used for high myopiaresulted in improved best-corrected visual acuity for about
a quarter of all operated eyes. For Phakic IOL AC and RLE,
the percentage of eyes that gained one line or more after
surgery was 23.4% and 25.6%, respectively. Most eyes with
a loss of one line or more after surgery were reported for
treating hyperopia with Epi-LASIK (37.1%).
The database was meant to offer an opportunity for com-
parison and bench-marking to the benefit of participating
surgeons, clinics, and their patients. The low inflow of data
indicates that European refractive surgeons have not de-
tected or appreciated this opportunity. This is in contrast
to a number of other ophthalmic databases, which have
generated much more interest from ophthalmologists. The
quality registry databases for cataract [14,15], corneal trans-
plants [16,17], retinopathy of prematurity [18] and age-
related macular degeneration [19] have all been successful.
Why is a quality registry for refractive surgery utilized
to a lesser extent than other ophthalmic quality regis-
tries? One possible reason is lack of awareness of the
existence of such a registry and its potential effect on
the quality of refractive surgery. However, Dutch re-
fractive surgeons have started to report their surgeries
to a national registry (personal communication: Ype
Henry). Swedish refractive surgeons will start to report
refractive surgeries in 2015 to the EUREQUO (personal
communication: Bo Andersén). Another possible reason is
that in many cases, even though the surgeon performs the
surgery, the referring optometrist/primary care ophthal-
mologist carries out postoperative follow-up. It is disap-
pointing that the major high street providers of laser
refractive surgery have not, to date, contributed to the
database.
One weakness of this study is that all data are self-
reported by self-selected surgeons interested in reporting to
a clinical database. We do not know whether these clinics
are a selection of well-performing clinics or just clinics in-
terested in quality control. If the majority of data come
from well-performing clinics there may be a bias towards a
very good outcome. However, the selection of surgical tech-
nique, indications, and trends over time should not be
affected. Other weaknesses include the use of different vis-
ual acuity test charts and that we do not have data on the
Lundström et al. Eye and Vision  (2015) 2:8 Page 9 of 9use of mitomycin C for surface laser treatments. A strength
of this study is the large amount of data from different
clinics and countries reflecting outcomes in real life. We
hope that the increasing interest in quality improvement
among refractive surgeons will result in more reporting to
the database in future. Furthermore, with a larger database,
more detailed analyses can be performed. The fields for
data collection, included in the web form, are currently
being reviewed.
Conclusion
A European registry for refractive surgery has been estab-
lished. The purpose of the registry is to improve quality of
care and serve as a reference database for benchmarking.
The number of reported surgical procedures increases with
around 4,000 cases added annually. The registry shows
changing trends in reported types of surgical procedure but
stable indications and good refractive outcomes. The fre-
quency of surgical complications and visual outcomes var-
ies between the surgical procedures.
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